Search

everythinglearnresearchcommunity

for

Search:↓

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

BeauTop improves hair growth in androgenetic alopecia patients.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Women with PCOS from minority backgrounds have worse mental health and quality of life.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

A comprehensive, personalized approach is needed for treating female pattern hair loss and obesity, involving multiple medical disciplines and lifestyle changes.

Lifestyle changes can help manage androgenetic alopecia.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Women with PCOS in Bangladesh face significant mental health issues, especially in rural areas.

Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Women with PCOS experience more psychological symptoms and need emotional support.

Women with PCOS have a higher risk of heart disease.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Finasteride 5 mg and topical minoxidil 5% effectively increase hair density in women, with finasteride 5 mg having the highest satisfaction.

Combining minoxidil with dutasteride and microneedling is more effective for female pattern hair loss than just dutasteride and microneedling.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Targeting IL-17 could help treat pattern hair loss.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.